Catalyst Pharmaceuticals, Inc. (CPRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 355 ALHAMBRA CIRCLE
CORAL GABLES, FL 33134
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments178,787148,247298,395256,065220,788197,796
Cash and cash equivalents178,787148,247298,395256,065210,912178,372
Short-term investments     9,87619,424
Receivables42,79633,40210,4399,3379,58710,552
Inventory, net of allowances, customer advances and progress billings10,75110,3286,8057,1327,8507,827
Inventory10,75110,3286,8057,1327,8507,827
Prepaid expense1,1561,2501,8458291,1461,637
Other undisclosed current assets7,4785,6843,3132,9473,1873,379
Total current assets:240,968198,911320,797276,310242,558221,191
Noncurrent Assets
Operating lease, right-of-use asset2,6412,7062,7702,8332,8952,957
Property, plant and equipment1,2031,285847882917925
Long-term investments and receivables      
Long-term investments      
Intangible assets, net (including goodwill)175,595184,08332,47133,051  
Intangible assets, net (excluding goodwill)175,595184,08332,47133,051  
Deposits noncurrent assets   9999
Deferred income tax assets23,48920,24218,73620,02920,93021,890
Total noncurrent assets:202,928208,31654,83356,80424,75125,781
TOTAL ASSETS:443,896407,227375,630333,114267,309246,972
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities52,50356,70957,58851,83727,19622,938
Taxes payable3,7441,855
Employee-related liabilities3,4122,853
Accounts payable4,4213,3913,9752,5292,3155,139
Accrued liabilities48,08253,31853,61342,15220,17317,799
Other undisclosed current liabilities    (7,156)(4,708) 
Total current liabilities:52,50356,70957,58844,68122,48822,938
Noncurrent Liabilities
Long-term debt and lease obligation:    3,6433,7293,813
Liabilities, other than long-term debt16,09916,85717,62114,749  
Other liabilities12,72313,38914,06414,749  
Operating lease, liability3,3763,4683,5573,6433,7293,813
Other undisclosed noncurrent liabilities     (3,729)(3,813)
Total noncurrent liabilities:16,09916,85717,62118,3923,7293,813
Total liabilities:68,60273,56675,20963,07326,21726,751
Equity
Equity, attributable to parent375,294333,661300,421270,041241,092220,221
Common stock107106105104103103
Additional paid in capital257,976254,114250,430245,514239,476236,191
Accumulated other comprehensive income (loss)19112432(130)(453)
Retained earnings (accumulated deficit)117,19279,43049,86224,3911,643(15,620)
Total equity:375,294333,661300,421270,041241,092220,221
TOTAL LIABILITIES AND EQUITY:443,896407,227375,630333,114267,309246,972

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues99,58285,36660,75757,24453,11343,089
Cost of revenue
(Cost of Goods and Services Sold)
(12,045)(9,946)(11,195)(9,665)(7,643)(5,890)
Gross profit:87,53775,42049,56247,57945,47037,199
Operating expenses(32,350)(39,811)(18,761)(22,477)(16,901)(19,833)
Other undisclosed operating loss(8,488)     
Operating income (loss):46,69935,60930,80125,10228,56917,366
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
1,8131,7042,207905(324)93
Income (loss) from continuing operations before income taxes:48,51237,31333,00826,00728,24517,459
Income tax expense (benefit)(10,750)(7,745)(7,537)(3,259)(6,626)(4,218)
Income (loss) from continuing operations:37,76229,56825,47122,74821,61913,241
Income before gain (loss) on sale of properties:22,74821,61913,241
Net income (loss) available to common stockholders, diluted:37,76229,56825,47122,74821,61913,241

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):37,76229,56825,47122,74821,61913,241
Other comprehensive income (loss)8(13) 162323(305)
Other undisclosed comprehensive income   172   
Comprehensive income (loss):37,77029,55525,64322,91021,94212,936
Other undisclosed comprehensive loss, net of tax, attributable to parent   (180)   
Comprehensive income (loss), net of tax, attributable to parent:37,77029,55525,46322,91021,94212,936

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: